Research News

Genetic marker may help target aspirin for colorectal cancer

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7281 (Published 30 October 2012) Cite this as: BMJ 2012;345:e7281

OpenUrlCrossRefMedlineWeb of Science

Researchers from the US have found a link between the use of aspirin and better survival in adults with a genetically distinct type of colorectal cancer. Among 161 men and women whose cancers had a mutation in the PIK3CA gene, use …

Sign in

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe